Early research (Phase 1)Looking for participantsNCT05755087
What this trial is testing
Tegavivint for Treating Patients With Relapsed or Refractory Large B-Cell Lymphoma
Who this might be right for
Recurrent Diffuse Large B-Cell Lymphoma Activated B-Cell TypeRecurrent Diffuse Large B-Cell Lymphoma Germinal Center B-Cell TypeRecurrent High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements+6 more
Lapo Alinari 18